Schurink C A M, Hoitsma M, Rozenberg-Arska M, Joore J C A, Hoepelman I M, Bonten M J M
Department of Medicine, Division of Acute Medicine and Infectious Diseases, University Medical Centre, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
Int J Antimicrob Agents. 2004 Apr;23(4):325-31. doi: 10.1016/j.ijantimicag.2003.08.013.
Obtaining diagnostic microbiological cultures before initiating empirical antimicrobial therapy is part of the diagnostic work-up of intensive care patients with a clinical suspicion of infection. However, it is unknown to what extent these cultures provide a microbiological cause of infection and to what extent antimicrobial therapy is influenced. During a 6-month period, all episodes of suspected clinical infection were analysed and categorised as non-microbiologically proven infection (non-MPI) or MPI. Effects of culture results on antibiotic therapy were analysed for episodes of respiratory tract infection. Invasive diagnostic techniques were not routinely used for diagnosis of respiratory tract infections. Among 212 patients admitted, 147 episodes of clinical suspicion of infection were recorded (104 for respiratory tract infection) and 1147 microbiological cultures were obtained (0.64 culture per patient day). Antibiotics were administered on 1111 (62%) of 1803 patients days. Of the respiratory tract infections, 571 cultures resulted in 49 (47%) MPI. Cover with empirical antibiotics was inappropriate in 7 of 104 cases (8%) of respiratory infections. In 12 cases (11.5%) empirical therapy could have been changed based on culture results. Negative cultures were never followed by cessation of therapy, but the duration of treatment was significantly shorter for non-MPI. Forty-seven percent of respiratory tract infections were microbiologically confirmed and, based on culture results, empirical antimicrobial therapy could have been influenced in 11.5% of cases of respiratory tract infections. These findings provide aspects to evaluate and improve the diagnostic work-up of infections in the ICU.
在开始经验性抗菌治疗前获取诊断性微生物培养物,是对临床怀疑感染的重症监护患者进行诊断检查的一部分。然而,这些培养物在多大程度上能提供感染的微生物病因以及在多大程度上影响抗菌治疗尚不清楚。在6个月期间,对所有疑似临床感染发作进行了分析,并分类为非微生物学证实的感染(非MPI)或MPI。对呼吸道感染发作分析了培养结果对抗生素治疗的影响。侵入性诊断技术未常规用于呼吸道感染的诊断。在212名入院患者中,记录了147次临床怀疑感染发作(104次为呼吸道感染),并获取了1147份微生物培养物(每位患者每天0.64份培养物)。在1803个患者日中,有1111个(62%)给予了抗生素。在呼吸道感染中,571份培养物中有49份(47%)为MPI。在104例呼吸道感染病例中有7例(8%)经验性抗生素覆盖不合适。在12例(11.5%)病例中,经验性治疗本可根据培养结果改变。培养结果为阴性时从未停止治疗,但非MPI的治疗持续时间明显较短。47%的呼吸道感染得到微生物学证实,基于培养结果,在11.5%的呼吸道感染病例中经验性抗菌治疗本可受到影响。这些发现为评估和改进ICU中感染的诊断检查提供了依据。